Drug · DIN 02460750
GLN-EZETIMIBE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since June 19, 2025; first marketed July 23, 2019.
- Drug Identification Number (DIN)
- 02460750
- Company (DIN owner)
- Glenmark Pharmaceuticals Canada Inc.Concord, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- July 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 20, 2017: NOC 18896Abbreviated New Drug Submission (ANDS)